An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
Clinical trial NCT00991757 · COMPLETED
Trial details
- NCT number
- NCT00991757
- Sponsor
- SK Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2010-10-01
- Enrollment
- 991
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.